Cargando…
Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors
Vesicular stomatitis virus (VSV) is a promising vector for vaccine and oncolysis, but it can also produce acute diseases in cattle, horses, and swine characterized by vesiculation and ulceration of the tongue, oral tissues, feet, and teats. In experimental animals (primates, rats, and mice), VSV has...
Autores principales: | Fang, Xinkui, Zhang, Shikuan, Sun, Xiaodong, Li, Jinjin, Sun, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126045/ https://www.ncbi.nlm.nih.gov/pubmed/22222871 http://dx.doi.org/10.1016/j.vaccine.2011.12.085 |
Ejemplares similares
-
Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSV(MT)) in golden syrian hamster
por: Ke, Yong, et al.
Publicado: (2023) -
Attenuated measles virus as a vaccine vector
por: Zuniga, Armando, et al.
Publicado: (2007) -
Recombinant vesicular stomatitis virus expressing the spike protein of genotype 2b porcine epidemic diarrhea virus: A platform for vaccine development against emerging epidemic isolates
por: Ke, Yong, et al.
Publicado: (2019) -
Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015) -
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2022)